Search

Your search keyword '"Wotherspoon, Andrew"' showing total 1,006 results
Start Over Author "Wotherspoon, Andrew"
1,006 results on '"Wotherspoon, Andrew"'

7. Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials

Author

Raimondi, Alessandra, Kim, Young Woo, Kang, Won Ki, Langley, Ruth E., Choi, Yoon Young, Kim, Kyoung-Mee, Nankivell, Matthew Guy, Randon, Giovanni, Kook, Myeong-Cherl, An, Ji Yeong, Grabsch, Heike I., Prisciandaro, Michele, Nichetti, Federico, Noh, Sung Hoon, Sohn, Tae Sung, Kim, Sung, Wotherspoon, Andrew, Morano, Federica, Cunningham, David, Lee, Jeeyun, Cheong, Jae-Ho, Smyth, Elizabeth Catherine, and Pietrantonio, Filippo

Published
2024
Full Text
View/download PDF

9. A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Author

El-Sharkawi, Dima, Sud, Amit, Prodger, Catherine, Khwaja, Jahanzaib, Shotton, Rohan, Hanley, Brian, Peacock, Victoria, Peng, Ying Ying, Arasaretnam, Anita, Sharma, Sarkhara, Aldridge, Frances, Sharma, Bhupinder, Wotherspoon, Andrew, Cheung, Betty, De Lord, Corinne, Johnston, Rosalynd, Kassam, Shireen, Pettengel, Ruth, Linton, Kim, Greaves, Paul, Cook, Lucy, Naresh, Kikkeri N., Cwynarski, Kate, Eyre, Toby A., Chau, Ian, Cunningham, David, and Iyengar, Sunil

Published
2023
Full Text
View/download PDF

11. Unraveling the genetics of transformed splenic marginal zone lymphoma

Author

Grau, Marta, López, Cristina, Navarro, Alba, Frigola, Gerard, Nadeu, Ferran, Clot, Guillem, Bastidas-Mora, Gabriela, Alcoceba, Miguel, Baptista, Maria Joao, Blanes, Margarita, Colomer, Dolors, Costa, Dolors, Domingo-Domènech, Eva, Enjuanes, Anna, Escoda, Lourdes, Forcada, Pilar, Giné, Eva, Lopez-Guerra, Mónica, Ramón, Olga, Rivas-Delgado, Alfredo, Vicente Folch, Laura, Wotherspoon, Andrew, Climent, Fina, Campo, Elias, López-Guillermo, Armando, Matutes, Estella, and Beà, Sílvia

Published
2023
Full Text
View/download PDF

12. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

Author

Beishuizen, Auke, Mellgren, Karin, Andrés, Mara, Auperin, Anne, Bacon, Chris M, Bomken, Simon, Burke, G A Amos, Burkhardt, Birgit, Brugieres, Laurence, Chiang, Alan K S, Damm-Welk, Christine, d'Amore, Emanuele, Horibe, Keizo, Kabickova, Edita, Khanam, Tasneem, Kontny, Udo, Klapper, Wolfram, Lamant, Laurence, Le Deley, Marie-Cecile, Loeffen, Jan, Macintyre, Elizabeth, Mann, Georg, Meyer-Wentrup, Friederike, Michgehl, Ulf, Minard-Colin, Veronique, Mussolin, Lara, Oschlies, Ilske, Patte, Catherine, Pillon, Marta, Reiter, Alfred, Rigaud, Charlotte, Ronceray, Leila, Salaverria, Itziar, Simonitsch-Klupp, Ingrid, Uyttebroeck, Anne, Verdu-Amoros, Jaime, Williams, Denise, Woessmann, Wilhelm, Wotherspoon, Andrew, Wrobel, Grazyna, Zimmermann, Martin, Attarbaschi, Andishe, and Turner, Suzanne D

Published
2023
Full Text
View/download PDF

16. Hairy Cell Leukemia

Author

Sena Teixeira Mendes, Larissa, Wotherspoon, Andrew, van Krieken, J. H. J. M., Series Editor, and Molina, Thierry J., editor

Published
2020
Full Text
View/download PDF

17. Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship

Author

Medeiros, L. Jeffrey, Marques-Piubelli, Mario L., Sangiorgio, Valentina F.I., Ruiz-Cordero, Roberto, Vega, Francisco, Feldman, Andrew L., Chapman, Jennifer R., Clemens, Mark W., Hunt, Kelly K., Evans, Mark G., Khoo, Christine, Lade, Stephen, Silberman, Mark, Morkowski, Jerzy, Pina, Edward M., Mills, Daniel C., Bates, Christopher M., Magno, Winston B., Sohani, Aliyah R., Sieling, Beth A., O'Donoghue, Joseph M., Bacon, Chris M., Patani, Neill, Televantou, Despina, Turner, Suzanne D., Johnson, Laura, MacNeill, Fiona, Wotherspoon, Andrew C., Iyer, Swaminathan P., Malpica, Luis E., Patel, Keyur P., Xu, Jie, and Miranda, Roberto N.

Published
2021
Full Text
View/download PDF

19. Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma.

Author

Tzioni, Maria-Myrsini, Clipson, Alexandra, Chen, Zi, Cucco, Francesco, Wotherspoon, Andrew, Dojcinov, Stefan, and Du, Ming-Qing

Subjects
DIFFUSE large B-cell lymphomas, LYMPHOMAS, MUCOSA-associated lymphoid tissue lymphoma, HAIRY cell leukemia, NUCLEOTIDE sequencing, SOMATIC mutation
Abstract

Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is a rare type of lymphoma that affects the spleen, bone marrow, and peripheral blood. It was initially thought to be a variant of splenic marginal zone lymphoma (SMZL) but is now recognized as a separate entity. SDRPL is difficult to diagnose based on peripheral blood and bone marrow samples alone, and a splenectomy is often necessary for an accurate diagnosis. The pathogenesis of SDRPL is not well understood, but it is associated with specific genetic changes, including mutations in BCOR, CCND3, NOTCH pathway genes, and MAP2K1. The prognosis and treatment response of SDRPL vary, but TP53 inactivation, through mutation and/or deletion, is associated with an aggressive clinical course. [Extracted from the article]

Published
2024
Full Text
View/download PDF

23. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage

Author

Carotenuto, Pietro, Amato, Francesco, Lampis, Andrea, Rae, Colin, Hedayat, Somaieh, Previdi, Maria C., Zito, Domenico, Raj, Maya, Guzzardo, Vincenza, Sclafani, Francesco, Lanese, Andrea, Parisi, Claudia, Vicentini, Caterina, Said-Huntingford, Ian, Hahne, Jens C., Hallsworth, Albert, Kirkin, Vladimir, Young, Kate, Begum, Ruwaida, Wotherspoon, Andrew, Kouvelakis, Kyriakos, Azevedo, Sergio Xavier, Michalarea, Vasiliki, Upstill-Goddard, Rosie, Rao, Sheela, Watkins, David, Starling, Naureen, Sadanandam, Anguraj, Chang, David K., Biankin, Andrew V., Jamieson, Nigel B., Scarpa, Aldo, Cunningham, David, Chau, Ian, Workman, Paul, Fassan, Matteo, Valeri, Nicola, and Braconi, Chiara

Published
2021
Full Text
View/download PDF

25. A wolf in sheep's clothing: enteropathy associated T‐cell lymphoma involving a nasal polyp masquerading as primary mucosal CD30‐positive T‐cell lymphoproliferative disorder.

Author

Attygalle, Ayoma D, Vroobel, Katherine M, Madej, Ewelina, Tzioni, Maria‐Myrsini, Zhang, Chunye, Chen, Zi, Ribeiro, Sara, Calvachini, Silvia, Sharma, Bhupinder, Alexander, Emma J, Wotherspoon, Andrew C, and Du, Ming‐Qing

Subjects
T-cell lymphoma, LYMPHOPROLIFERATIVE disorders, NASAL polyps, INTESTINAL diseases, ANAPLASTIC large-cell lymphoma
Abstract

This article discusses a case study of an 81-year-old woman who presented with nose bleeds and a nasal polyp. The biopsy revealed features of anaplastic large-cell lymphoma (ALCL), but further testing showed that the diagnosis was actually enteropathy-associated T-cell lymphoma (EATL) involving the nasal polyp. The patient also had a history of coeliac disease (CD) and jejunal resection revealed EATL and refractory coeliac disease type 2 (RCD2). The article highlights the challenges in diagnosing and distinguishing between different types of lymphomas and emphasizes the importance of clinical correlation and awareness of relevant clinical details. The patient received treatment but unfortunately died 9 months after the initial presentation. [Extracted from the article]

Published
2024
Full Text
View/download PDF

26. Corrigendum to “Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.” [Modern Pathology 34 (2021) 2154–2167]

Author

Medeiros, L. Jeffrey, primary, Marques-Piubelli, Mario L., additional, Sangiorgio, Valentina F.I., additional, Ruiz-Cordero, Roberto, additional, Vega, Francisco, additional, Feldman, Andrew L., additional, Chapman, Jennifer R., additional, Clemens, Mark W., additional, Hunt, Kelly K., additional, Evans, Mark G., additional, Khoo, Christine, additional, Lade, Stephen, additional, Silberman, Mark, additional, Morkowski, Jerzy, additional, Pina, Edward M., additional, Mills, Daniel C., additional, Bates, Christopher M., additional, Magno, Winston B., additional, Sohani, Aliyah R., additional, Sieling, Beth A., additional, O’Donoghue, Joseph M., additional, Bacon, Chris M., additional, Patani, Neill, additional, Televantou, Despina, additional, Turner, Suzanne D., additional, Johnson, Laura, additional, MacNeill, Fiona, additional, Wotherspoon, Andrew C., additional, Iyer, Swaminathan P., additional, Malpica, Luis E., additional, Patel, Keyur P., additional, Xu, Jie, additional, and Miranda, Roberto N., additional

Published
2023
Full Text
View/download PDF

27. CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

Author

Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue, Begum, Ruwaida, Chau, Ian, Johnson, Peter, Ardeshna, Kirit M, Hawkes, Eliza A, Macheta, Marian P, Collins, Graham P, Radford, John, Forbes, Adam, Hart, Alistair, Montoto, Silvia, McKay, Pamela, Benstead, Kim, Morley, Nicholas, Kalakonda, Nagesh, Hasan, Yasmin, Turner, Deborah, and Cunningham, David

Published
2018
Full Text
View/download PDF

28. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma

Author

Lampis, Andrea, Carotenuto, Pietro, Vlachogiannis, Georgios, Cascione, Luciano, Hedayat, Somaieh, Burke, Rosemary, Clarke, Paul, Bosma, Else, Simbolo, Michele, Scarpa, Aldo, Yu, Sijia, Cole, Rebecca, Smyth, Elizabeth, Mateos, Javier Fernández, Begum, Ruwaida, Hezelova, Blanka, Eltahir, Zakaria, Wotherspoon, Andrew, Fotiadis, Nicos, Bali, Maria Antonietta, Nepal, Chirag, Khan, Khurum, Stubbs, Mark, Hahne, Jens C., Gasparini, Pierluigi, Guzzardo, Vincenza, Croce, Carlo M., Eccles, Suzanne, Fassan, Matteo, Cunningham, David, Andersen, Jesper B., Workman, Paul, Valeri, Nicola, and Braconi, Chiara

Published
2018
Full Text
View/download PDF

29. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

Author

Lindsay, Colin R., Shaw, Emily C., Blackhall, Fiona, Blyth, Kevin G., Brenton, James D., Chaturvedi, Anshuman, Clarke, Noel, Dick, Craig, Evans, Thomas R.J., Hall, Geoff, Hanby, Andrew M., Harrison, David J., Johnston, Stephen R.D., Mason, Malcolm D., Morton, Dion, Newton-Bishop, Julia, Nicholson, Andrew G., Oien, Karin A., Popat, Sanjay, Rassl, Doris, Sharpe, Rowena, Taniere, Phillipe, Walker, Ian, Wallace, William A., West, Nicholas P., Butler, Rachel, Gonzalez de Castro, David, Griffiths, Mike, Johnson, Peter W.M., Rehal, Pauline, Butler, Samantha, Smith, Matthew, Doak, Rachel, Tanska, Anna, Halford, Graham, James, Lisa, Kotara, Chris, Masson, Gareth, Clokie, Sam, Bell, Jennie, Macdonald, Fiona, De Castro, David Gonzalez, Thompson, Lisa, Mair, Debbie, Lillis, Suzanne, Wren, Dorte, Hollifield, Robert, Dover, Keeda, Maurya, Manisha, Brooks, Damian, Gomez, Belen, Grady, Lisa, Jones, Thomas, Hooper, Chantal, Webster, Daphne, Travis, Jolyon, Ogwuru, Stephanie, Gazdova, Jana, Collins, Denise, Chapman, Elaine, Leavey, Lisa, Proszek, Paula, Hulkki, Sanna, Collins, V.Peter, Ibrahim, Ash, Brown, Kat, Burge, Jo, Burnett, Karen, Devonshire, Ginny, Moseley, Ellen, Haynes, Bev, Hodgkin, Charlotte, Jimenez-linan, Merche, Jones, Linda, Kenyon, Gilly, Mahler-araujo, Betania, Payne, Karen, Piper, Jo, Richardson, Sue, Rytina, Ed, Warren, Anne, Coker, Liz, Godsall, Gemma, Arends, Mark, O’Neill, Amanda, Rintoul, Katy, Goymer, Donna, Taylor, Julie, Matthews, Claire, Bhayani, Harshil, Osalador, Tina, Niwaz, Zakiya, Higgins, Anna, Bamsey, Olivia, Salter, Janine, Renouf, Louise, Noel-Storr, Glenn, Roberts, Helen, Gierejko, Kasia, Knapman, Paola, Wotherspoon, Andrew, Stamp, Gordon, Attygailye, Ayoma, Hazell, Steve, Osin, Peter, Nerurkar, Ash, Francis, Steven, Runde, Marion, Arch, Jo, Chitnis, Xavier, Siu, Bernard, Townsend, Debra, Hennelly, Laura, Taylor, Natalie, Johnson, Bernadette, Banerjee, Susie, Pyle, Lynda, Hamill, Monica, Gyertson, Jenny, George, Angela, Patel, Krishna, Pearce, Karla, Edmonds, Kim, Sarker, Sarah, Eeles, Rosalind, Bancroft, Liz, Thomas, Sarah, Kano, Yukie, Rowland, Lisa, Brooks, Karen, O’brien, Mary, Bhosle, Jaishree, Priest, Kathy, Ayite, Bee, Severn, Jo, Beedham, Helen, Lucas, Nicky, Tye, Kim, Lorentzos, Alison, Webb, Janine, Kerr, Sarah, Corestav, Lisa, Bottero, Diego, Jell, Laura, Thomas, Janet, Marriott, Cheryl, Rajah, Neil, Cole, Andy, Ly, Dieu, Taniere, Philippe, O’sullivan, Brendan, Swift, Clare, Hughes, Frances, Neil, Desley, Hanby, Andrew, Banks, Roz, Ajayi, Dolapo, Barclay, Alison, Bishop, Julia Newton, Beirne, Debbie, Bernard, Andrew, Berry, Maxine, Bentley, Jo, Bishop, Tim, Chambers, Amy, Clarke, Jude, Crossley, Anne, Gahir, Narinder, Gibson, Debbie, Good, Rona, Grosios, Konstantina, Harnden, Pat, Hasler, Kate, Hindmarch, Damien, Jackson, Sharon, Johnstone, Colin, Jones, Anne-marie, Lambert, Gil, Lane, Sally, Mcnicholas, Nicola, Millican-Slater, Rebecca, Moriaty, Cath, Newsham, Alex, O’connell, Kara, Ripley, Lisa, Sebag-Montefiore, David, Simpson, Mary, Speirs, Val, Sugden, Joh, Tate, Lauren, Tidswell, Emma, Twelves, Chris, Walker, Christy, Waterhouse, Barry, Waugh, Martin, White, Louise, Wright, Elizabeth, Rogan, Jane, Ashton, Garry, Abbey, Caron, Greenhalgh, Michelle, Nonaka, Daisuke, Shing, Elwyn, Gibbard, Carmen, Burton, Georgina, Fawkes, Naomi, Marsden, Angela, Waddington, Rachael, Harrison, Phil, Moghadam, Shahrzad, Murray, Kate, Brown, Sarah, Mitchinson, Christy, Booton, Richard, Shah, Rajesh, Harrison, David, Oniscu, Anca, Wallace, William, Rae, Frances, Marshall, Craig, Mcleod, Linda, Charles, Morag, Sutherland, Sarah Jane, Dawson, Carol, Mitchell, Paul, Maclellan, Alex, Muir, Sandra, Johnstone, Lynne, O’connor, John, Johnstone, Shirley, Mcpherson, Jim, Hair, Jane, Pignatelli, Massimo, Armstrong, Roma, Oien, Karin, Evans, Jeff, Burgoyne, Margaret, Blessing, Karen, Duthie, Fraser, Moyes, Colin, Mallon, Elizabeth, Millan, David, Roberts, Fiona, Seywright, Morag, Fraser, Siobhan, Ford, Ian, Kean, Sharon, Flood, Marion, Grant, David, Mcdonald, Claire, Moffat, Tom, Mclelland, Hugh, Kyle, Alistair, Cameron, Graham, Wright, Martin, Kenny, Stephen, Mcauslan, Karen, Jones, Andrew, Fitzsimons, Ted, Graham, Fiona, Bell, Alexandra, Duffy, Phil, Fisher, Alec, Smith, Alexis, Shannon, Elaine, Woods, Bryan, Hutchison, Colin, Booth, Angela, Duffy, Lyndsay, Mcculloch, Gillian, Sadiq, Hudda, Deakin, Susan, Haywood, Steven, Mason, Malcolm, Chester, John, Parry-jones, Alison, Macarthur, Abby, Williams, Suzanne, Griffiths, David, Morgan, Fiona, and Bailey, Hazel

Published
2018
Full Text
View/download PDF

31. Outcomes of patients treated with RCHOP with a PET adapted approach for consolidative radiotherapy: a retrospective single centre study at the Royal Marsden hospital

Author

Li, Su, primary, Sharma, Bhupinder, additional, Yusuf, Siraj, additional, Michalarea, Vasiliki, additional, Gleeson, Mary, additional, Hickmott, Laura, additional, Wotherspoon, Andrew, additional, Attygalle, Ayoma D., additional, Vroobel, Katherine, additional, O'Connor, Simon, additional, Du, Yong, additional, Kuhnl, Andrea, additional, Iyengar, Sunil, additional, El-Sharkawi, Dima, additional, Chau, Ian, additional, and Cunningham, David, additional

Published
2023
Full Text
View/download PDF

34. Relapses in early‐stage follicular lymphoma frequently develop via a divergent evolution from their clonally related precursor cells.

Author

Makker, Jasmine, Wotherspoon, Andrew, Tzioni, Maria‐Myrsini, Chen, Zi, Guo, Sarah, Jiang, Dan, Casa, Calogero, Cucco, Francesco, and Du, Ming‐Qing

Subjects
FOLLICULAR lymphoma, DISEASE relapse, NUCLEOTIDE sequencing, CANCER relapse, LYMPHOMAS, PERIODICAL publishing
Abstract

Follicular lymphoma (FL) develops through a stepwise acquisition of cooperative genetic changes with t(14;18)(q32;q21)/IGH::BCL2 occurring early at the pre‐B stage of B‐cell development. Patients with FL typically show an indolent clinical course, remitting and relapsing with the eventual development of resistance to treatments. Interestingly, the majority of transformed FL do not progress directly from FL but originate from their clonally related lymphoma precursor (CLP) cells. To examine whether such divergent tumour evolution also underpins the relapses in patients with early‐stage FL, we investigated by targeted next‐generation sequencing 13 cases (stage I = 9, stage II = 4), who showed complete remission (mean: 5 years; range: 1–11.5 years) following local radiotherapy but subsequently relapsed (≥2 in 5). A clonal relationship between the diagnostic FL and relapses was confirmed in 11 cases. In six cases, common and distinct variants were seen between the paired diagnostic and relapsed lymphomas, indicating their divergent evolution from a CLP. In two cases, different B‐cell clones were involved in the diagnostic and relapsed lymphomas, including one case involving two different BCL2 translocations. In the remaining five cases, the relapsed lymphoma developed via a linear progression (n = 4) or a mixed evolutionary path (n = 1). These findings may bear important implications in the routine diagnosis and management of relapsed FL. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

36. Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.

Author

Walewska, Renata, Eyre, Toby A., Barrington, Sally, Brady, Jessica, Fields, Paul, Iyengar, Sunil, Joshi, Anurag, Menne, Tobias, Parry‐Jones, Nilima, Walter, Harriet, Wotherspoon, Andrew, and Linton, Kim

Subjects
HELICOBACTER pylori infections, HEPATITIS C, HEMATOLOGY, MUCOSA-associated lymphoid tissue lymphoma, DIFFUSE large B-cell lymphomas, LYMPHOMAS, HODGKIN'S disease
Abstract

This document is a guideline published in the British Journal of Haematology that provides healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL). MZL is a group of clinically indolent mature B-cell lymphomas that arise from memory B cells in the marginal zones of secondary lymphoid tissues. The guideline discusses the different subtypes of MZL, diagnostic methods, and potential aetiological factors. It also includes information on treatment options for different stages of MZL, including radiotherapy, systemic therapy, and targeted agents. The document emphasizes the importance of individualized patient care and shared decision making. [Extracted from the article]

Published
2024
Full Text
View/download PDF

41. Divergent evolution of metachronous follicular lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue from a common precursor

Author

Tzioni, Maria-Myrsini, Wotherspoon, Andrew, Chen, Zi, Cucco, Francesco, Makker, Jasmine, Du, Ming-Qing, Tzioni, Maria-Myrsini [0000-0001-9298-2045], Makker, Jasmine [0000-0002-5519-3351], Du, Ming-Qing [0000-0002-1017-5045], and Apollo - University of Cambridge Repository

Subjects
BCL2 translocation, EMZL, follicular lymphoma, mutational profiling, clonal evolution
Abstract

The translocation t(14;18)(q32:q21)/IGH::BCL2 occurs at the pre-B stage of B-cell development in the bone marrow and is insufficient for malignant transformation, although it leads to the formation of in situ follicular B-cell neoplasia (ISFN). Despite that, the translocation is the genetic hallmark of follicular lymphoma (FL), it occurs infrequently in metachronous/synchronous lymphomas, including extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (EMZL), mantle cell lymphoma, and Hodgkin's lymphoma. In each of these scenarios, the two lymphomas often appear to be clonally related by analyses of IGH::BCL2 and/or rearranged IG genes. However, it remains largely unknown whether one lymphoma originates from the other or they develop independently. We studied five cases of metachronous EMZL and FL. In four cases, the two lymphomas were clonally related, as shown by identical IGH::BCL2 and/or rearranged IG genes or shared mutations. There were common and unique mutations between the paired EMZL and FL, indicating that they developed independently from a common premalignant cell population, harbouring IGH::BCL2 in three cases. Furthermore, case 1 presented with three metachronous FLs, and all of them originated from a common precursor cell population via divergent evolution. Our findings highlight the multi-malignant potential of IGH::BCL2-positive B-cells. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Published
2023
Full Text
View/download PDF

42. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Author

O'Connell, Rachel L., Sharma, Bhupinder, El-Sharkawi, Dima, Wotherspoon, Andrew, Attygalle, Ayoma D., MacNeill, Fiona, Khan, Aadil A., and Tasoulis, Marios-Konstantinos

Abstract

Introduction: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon type of non-Hodgkin lymphoma, associated with breast implant capsules. Despite improvements in our understanding of BIA-ALCL, communicating the prognosis to patients remains challenging due to limited long-term follow-up data. This has important implications for decision-making, including recommendations for subsequent reconstructive procedures. The aim of this study was to assess the longer-term oncological outcomes of patients receiving multidisciplinary treatment for BIA-ALCL. Methods: This was a retrospective cohort study of BIA-ALCL patients treated at a tertiary referral unit. The data are presented using simple descriptive statistics. Results: Between 2015 and 2022, 18 BIA-ALCL patients were treated at our institution. The median age at diagnosis was 48.5 (IQR 41–55) years. Ten patients developed BIA-ALCL after cosmetic breast augmentation, and 8 after breast reconstruction following mastectomy for cancer. All patients had a history of textured implant insertion. The median time from first implant surgery to diagnosis was 8.5 (IQR 7–12) years. All patients underwent en-bloc total capsulectomy with implant removal, and 2 received systemic therapy. Fifteen patients had Stage I (IA–IC) disease, 2 had Stage IIA and 1 Stage III BIA-ALCL, based on the TNM classification system. At a median follow-up of 45 (IQR 15–71) months, there were no episodes of local or systemic relapse or death. Conclusions: Surgical management for BIA-ALCL is sufficient in early-stage disease, and associated with excellent oncological outcomes. This information is reassuring for patients when discussing recurrence risk. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

43. Table 1 from Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy

Author

Smyth, Elizabeth, primary, Zhang, Shenli, primary, Cunningham, David, primary, Wotherspoon, Andrew, primary, Soong, Richie, primary, Peckitt, Clare, primary, Valeri, Nicola, primary, Fassan, Matteo, primary, Rugge, Massimo, primary, Okines, Alicia, primary, Allum, William, primary, Stenning, Sally, primary, Nankivell, Matthew, primary, Langley, Ruth, primary, and Tan, Patrick, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Data from MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer

Author

Khakoo, Shelize, primary, Carter, Paul David, primary, Brown, Gina, primary, Valeri, Nicola, primary, Picchia, Simona, primary, Bali, Maria Antonietta, primary, Shaikh, Ridwan, primary, Jones, Thomas, primary, Begum, Ruwaida, primary, Rana, Isma, primary, Wotherspoon, Andrew, primary, Terlizzo, Monica, primary, von Loga, Katharina, primary, Kalaitzaki, Eleftheria, primary, Saffery, Claire, primary, Watkins, David, primary, Tait, Diana, primary, Chau, Ian, primary, Starling, Naureen, primary, Hubank, Michael, primary, and Cunningham, David, primary

Published
2023
Full Text
View/download PDF

50. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

Author

Beishuizen, Auke, Mellgren, Karin, Andrés, Mara, Auperin, Anne, Bacon, Chris M, Bomken, Simon, Burke, GA Amos, Burkhardt, Birgit, Brugieres, Laurence, Chiang, Alan KS, Damm-Welk, Christine, d'Amore, Emanuele, Horibe, Keizo, Kabickova, Edita, Khanam, Tasneem, Kontny, Udo, Klapper, Wolfram, Lamant, Laurence, Le Deley, Marie-Cecile, Loeffen, Jan, Macintyre, Elizabeth, Mann, Georg, Meyer-Wentrup, Friederike, Michgehl, Ulf, Minard-Colin, Veronique, Mussolin, Lara, Oschlies, Ilske, Patte, Catherine, Pillon, Marta, Reiter, Alfred, Rigaud, Charlotte, Roncery, Leila, Salaverria, Itziar, Simonitsch-Klupp, Ingrid, Uyttebroeck, Anne, Verdu-Amoros, Jaime, Williams, Denise, Woessmann, Wilhelm, Wotherspoon, Andrew, Wrobel, Grazyna, Zimmermann, Martin, Attarbaschi, Andishe, Turner, Suzanne D, European Intergroup for Childhood Non-Hodgkin Lymphoma, Turner, Suzanne [0000-0002-8439-4507], and Apollo - University of Cambridge Repository

Subjects
Europe, Young Adult, Lymphoma, Non-Hodgkin, Humans, Child
Abstract

The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results